Multiple System Atrophy Coalition Grants
The Multiple System Atrophy Coalition requests pre-proposal grant applications for research relevant to the improved treatment of Multiple System Atrophy patients.
Applications are accepted from anywhere in the world. Maximum seed grant amount is $50,000 for a one-year grant with the option to renew upon satisfactory review and submission of a year 2 research plan.
CALL TOPIC: The Multiple System Atrophy Coalition seeks novel ideas to answer one of two questions:
“How do we treat Multiple System Atrophy?”
“How can we evaluate and improve quality of care for multiple system atrophy patients?
Specifically:
1. Can we develop better symptomatic therapies to improve the quality of life of MSA patients?
There is an unmet need to explore therapies that may improve the quality of daily life of MSA patients. Therefore, the MSA Coalition seeks pre-proposal grant applications for research aimed at identifying and testing potential therapies with the goal of relieving symptoms and improving quality of life for MSA patients.
2. Can we evaluate and improve methodologies to provide care for MSA patients at various points in time during the MSA journey?
There is an unmet need to evaluate and improve the care MSA patients need and currently receive, and determine the best approaches to providing such care. Therefore, the MSA Coalition seeks pre-proposal grant applications for research aimed at identifying and testing potential care resources or systems with the goal of providing the MSA patient with the best quality of life (QoL) possible.
OR
3. Can we help develop novel biomarkers or discover disease mechanisms or advance potential MSA disease-modifying therapies more rapidly through the drug development process?
There continues to be an urgent need to develop accurate diagnostic tests, discover the underlying cause and advance disease-modifying therapies to slow, stop or reverse the progression of MSA. Novel undeveloped therapies as well as existing interventions approved or in progress for other diseases may be effective against multiple system atrophy. All potential therapies must first be identified and tested in appropriate preclinical models of MSA before advancing to patient trials. Therefore, the MSA Coalition seeks pre-proposal grant applications for research aimed at developing MSA biomarkers or uncovering MSA pathogenesis or screening and developing potential MSA therapies with the ultimate goal of enabling Phase 2 and Phase 3 trials to reach patients more rapidly.
All applications must be submitted to The MSA Coalition by April 30, 2023 – 11:59pm US Eastern.
Through this initiative, the Multiple System Atrophy Coalition invites pre-proposal grant applications from professionals committed to conducting novel, emerging, or innovative research that could lead to improved treatment of Multiple System Atrophy.
More details
Website: https://www.multiplesystematrophy.org/msa-research/grants/